Exxon tries to put the worst behind it with a $20 billion writedown
- Top U.S. oil producer Exxon Mobil on Monday said it would write down the value of $17 billion to $20 billion in natural gas properties, its biggest-ever impairment, and slash spending next year to its lowest level in 15 years.
- The oil major is reeling from the Covid-19 pandemic's impact on energy demand and prices, and is trying to protect a rich shareholder payout that is yielding 8.6% and costs nearly $15 billion a year.
Exxon Mobil on Monday said it would write down the value of natural gas properties by $17 billion to $20 billion, its biggest-ever impairment, and slash project spending next year to its lowest level in 15 years.
The oil major is reeling from the sharp decline in oil demand and prices from the Covid-19 pandemic and a series of bad bets on projects when prices were much higher. New cost cuts aim to protect a $15 billion a year shareholder payout that many analysts believe is unsustainable without higher prices.
The writedown lays bare the size of the miscalculation that the company made in 2010 when it paid $30 billion for U.S. shale producer XTO Energy as natural gas prices went into a decade-long decline. The writedown also includes properties in Argentina and western Canada.
While smaller than the up to $30 billion charge the company forecast a month ago, the quarterly charge to earnings reflects the company's recent reduction in its outlook for oil and gas prices.
Exxon will continue initiatives in offshore Brazil, Guyana, the Permian Basin shale field in the United States, and in performance chemicals despite plans to implement deeper spending cuts, it said. Not mentioned was its $30 billion Mozambique liquefied natural gas project, which sources do not expect final investment decision on until early 2022.
"Recent exploration success and reductions in development costs of strategic investments have further enhanced the value of our industry-leading investment portfolio," said Chief Executive Darren Woods.
Business conditions are continuing to show signs of improvement despite the pandemic, he said.
Exxon shares fell 5% in late trading to $38.13 and are down by half in the last five years.
The impairment charge "further worsens the company's already substantial jump in financial leverage," said Pete Speer, senior analyst at Moody's Investors Service. "With this charge added to the big rise in debt this year, we see ExxonMobil's debt/capitalization rising to nearly 30%, from just over 20% at the start of 2020."
Next year's spending will fall, to between $16 billion to $19 billion, but Exxon could increase spending by 2025 to more than this year's about $23 billion level, Woods said.
The plan to return to higher levels of capital expense struck investor Mark Stoeckle, senior portfolio manager at Adams Funds, as unusual.
"In this environment, it makes no sense to me at all. What's the hurry?" he said. "I don't think it's going to help them with investors."
Exxon said last month it could cut 14,000 employees, or 15% of its global workforce, by the end of 2021.
CDC says 74% of people infected in Massachusetts Covid outbreak were fully vaccinated
A Harvard-trained doctor shares the 'super easy' stretch she does every day to relieve lower back pain
Why this couple moved most of their money from mutual funds to ETFs after the 2008 market crash
Disney tells salaried and non-union employees in the US they must be vaccinated by end of September
Trump tax returns must be released by IRS to Congress, Justice Department says